Kim Anderson

Kim Anderson has over 20 years of experience in finance and accounting. Kim'smost recent position was as a Senior Director of Financial Planning & Analysis at Syndax Pharmaceuticals, starting in April 2023. Prior to that, they served as a Senior Director of Finance and Investor Relations at Nabriva Therapeutics plc from September 2017 to March 2023. Before joining Nabriva Therapeutics, Kim worked at Vitae Pharmaceuticals as a Director of Financial Planning and Analysis from August 2015 to May 2017. Kim also held positions at Shire Pharmaceuticals as an AD of R&D Finance from February 2014 to April 2015, and at ViroPharma Incorporated as an Assistant Director of Global R&D Finance, Manager of Development Finance, and Finance Specialist from January 2013 to January 2014, September 2006 to January 2013, and October 2004 to September 2006, respectively. Kim began their career at Deloitte & Touche as a Senior Auditor from September 2001 to October 2004.

Kim Anderson earned a Bachelor's degree in Accounting from the University of Delaware in 2001. Kim is also certified as a Public Accountant by the state of Pennsylvania.